Suppr超能文献

Tokuhashi评分是否适用于评估伊朗脊柱转移瘤患者术前的预期寿命?

Is Tokuhashi score suitable for evaluation of life expectancy before surgery in Iranian patients with spinal metastases?

作者信息

Mollahoseini Reza, Farhan Farshid, Khajoo Ashkan, Jouibari Mir Abolfazl Motiei, Gholipour Fatemeh

机构信息

Assistant Professor, Department of Neurosurgery, Firoozgar Medical Center, Tehran University of Medical sciences, Tehran, Iran.

出版信息

J Res Med Sci. 2011 Sep;16(9):1183-8.

Abstract

BACKGROUND

One of the most important selection criteria for spinal metastases surgery is life expectancy and the most important system for this prediction has been proposed by Tokuhashi. The aim of this study was to evaluate predictive value of the Tokuhashi score for life expectancy in Iranian patients with spinal metastases one year after diagnosis.

METHODS

From February 2007 to March 2009, of 180 patients suffering spinal metastatic tumors, 71 patients were excluded. This left a study population of 109 patients with known malignant metastases to spine (56 females and 53 males; mean age, 57 ± 12 years). Tokuhashi revised evaluation system for the prognosis of metastatic spinal tumors was used for all patients. The survival period predicted by this system for the prognosis and the actual survival period after 1 year follow up were evaluated.

RESULTS

The predicted survival according to Tokuhashi prognostic scoring system was less than 6 months in 38(34.9%) patients, 6-12 months in 39(35.8%) patients and 1 year or more in 32(29.4%) patients. 39 (35.8%) patients died at first six-month of the follow up, 28(25.7%) patients at the second six-month period and 42(38.5%) patients were alive at the end of the year. There was no significant difference between predicted and actual survival time (p = 0.116).

CONCLUSIONS

Present study showed that the Tokuhashi revised scoring system may be practicable and highly predictive preoperative scoring system for patients with spinal metastases in Iran.

摘要

背景

脊柱转移瘤手术最重要的选择标准之一是预期寿命,Tokuhashi提出了预测预期寿命的最重要系统。本研究的目的是评估Tokuhashi评分对伊朗脊柱转移瘤患者诊断后一年预期寿命的预测价值。

方法

2007年2月至2009年3月,180例脊柱转移性肿瘤患者中,71例被排除。剩余109例已知脊柱恶性转移瘤患者作为研究对象(56例女性,53例男性;平均年龄57±12岁)。所有患者均采用Tokuhashi修订的脊柱转移性肿瘤预后评估系统。评估该系统预测的预后生存期和1年随访后的实际生存期。

结果

根据Tokuhashi预后评分系统,预测生存期小于6个月的患者有38例(34.9%),6 - 12个月的患者有39例(35.8%),1年或更长时间的患者有32例(29.4%)。39例(35.8%)患者在随访的前6个月死亡,28例(25.7%)患者在第二个6个月期间死亡,42例(38.5%)患者在年底仍存活。预测生存期与实际生存期之间无显著差异(p = 0.116)。

结论

本研究表明,Tokuhashi修订评分系统可能是伊朗脊柱转移瘤患者可行且预测性高的术前评分系统。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5a0/3430043/b7e30845b5f0/JRMS-16-1183-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验